Clinical Trials in Pittsburgh

Showing 17541-17560 of 21,047 trials

Determining Changes in Brain Structure Associated With Symptoms of Late-life Depression

NCT00178087

This study will determine the changes in brain structure and function that are responsible for mood and cognition changes that are sometimes associated with late-life depression.

Late-Life Depression

University of Pittsburgh331 participantsStarted Aug 2005

Pittsburgh, Pennsylvania, United States • Pittsburgh, Pennsylvania, United States

COMPLETEDNA< 1 mile

Systematic Management of High Cholesterol Utilizing Computer Monitoring

NCT00133094

Employing a physician-directed case management system, utilizing a Certified Registered Nurse Practitioner (CRNP) in conjunction with computer-based decision support technology (CDST) will result in significantly lower total cholesterol and a lower low density lipoprotein cholesterol in a group of subjects enrolled in a general medical clinic compared to subjects managed by primary care providers in the usual care group.

Hypercholesterolemia

US Department of Veterans Affairs220 participantsStarted Jun 2006

Pittsburgh, Pennsylvania, United States

COMPLETEDPhase 3< 1 mile

Efficacy and Safety of Empagliflozin (BI 10773) / Linagliptin (BI 1356) Fixed Dose Combination in Treatment naïve and Metformin Treated Type 2 Diabetes Patients

NCT01422876

This trial will evaluate use of BI 10773/linagliptin once daily (qd) fixed dose combination (FDC) in treatment naïve and metformin treated patients with type 2 diabetes mellitus to support approval by regulatory authorities.

Diabetes Mellitus, Type 2

Boehringer Ingelheim1,405 participantsStarted Aug 2011

Birmingham, Alabama, United States • Foley, Alabama, United States • Mobile, Alabama, United States +208 more locations

Determining Changes in Brain Structure Associated With Symptoms of Late-life Depression

Systematic Management of High Cholesterol Utilizing Computer Monitoring

Efficacy and Safety of Empagliflozin (BI 10773) / Linagliptin (BI 1356) Fixed Dose Combination in Treatment naïve and Metformin Treated Type 2 Diabetes Patients

Find Trials by Condition in Pittsburgh

Study of Abatacept Versus Placebo to Assess the Prevention of Rheumatoid Arthritis (RA) in Adult Patients

A Study to Determine the Effect of WelChol Tablets on Cholesterol in Patients Who Have Been Taking Pravastatin for at Least 4 Weeks.

A Study to Determine the Effect of WelChol Tablets on Cholesterol in Patients Who Have Been Taking Atorvastatin for at Least 4 Weeks.

Safety and Efficacy Study of Ad2/Hypoxia Inducible Factor (HIF)-1α/VP16 Gene Transfer in Patients With Intermittent Claudication

Study of REGN1400 Alone and in Combination With Erlotinib or Cetuximab in Patients With Certain Types of Cancer

NET-PD LS-1 Creatine in Parkinson's Disease

An Exploratory Study of the Effect of Treatment Interruption on Safety of Exenatide in Patients With Type 2 Diabetes

Phase 3 Extension Study of the Safety and Efficacy of Aldurazyme® (Laronidase) in Mucopolysaccharidosis I (MPS I) Patients

An Open-label, Randomized, Multicenter Phase IIIb Study to Assess the Efficacy, Safety and Tolerance of BERIPLEX® P/N (Kcentra) Compared With Plasma for Rapid Reversal of Coagulopathy Induced by Vitamin K Antagonists in Subjects Requiring an Urgent Surgical Procedure

Efficacy & Safety Study of Oral Aripiprazole in Adolescents With Schizophrenia

A Dose-optimization Study of Aldurazyme® (Laronidase) in Patients With Mucopolysaccharidosis I (MPS I) Disease

Study to Compare Welchol and TriCor to TriCor Alone in Patients With High Cholesterol

Clinical Study of Aldurazyme in Patients With Mucopolysaccharidosis (MPS) I

A Pilot Study of Effects of Exenatide on Body Weight in Non-Diabetic, Obese Patients

Effect on Weight Loss of Exenatide Versus Placebo

Group Visits to Improve Hypertension Management

Fibroid Ablation Study